CAMP4 Therapeutics
CAMP
29 hedge funds and large institutions have $84.6M invested in CAMP4 Therapeutics in 2025 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 10 reducing their positions, and 8 closing their positions.
397% more capital invested
Capital invested by funds: $17M → $84.6M (+$67.6M)
81.67% more ownership
Funds ownership: 58.25% → 139.92% (+82%)
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
0% more funds holding
Funds holding: 29 → 29 (0)
0% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 8
60% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$8.6M |
| 2 |
VC
Vivo Capital
Palo Alto,
California
|
+$7.26M |
| 3 |
5VM
5AM Venture Management
San Francisco,
California
|
+$5.45M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.47M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$3.63M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$135K |
| 2 |
Millennium Management
New York
|
-$70.3K |
| 3 |
Goldman Sachs
New York
|
-$38.4K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$28.5K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$27.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Barclays
London,
United Kingdom
| $210 | +$130 | +70 | New |
|
|
SS
27
SBI Securities
Tokyo,
Japan
| $45 | -$9 | -5 | -25% |
|
28
Morgan Stanley
New York
| $9 | -$3.12K | -1,684 | -100% |
|
|
29
Goldman Sachs
New York
| – | -$38.4K | -26,511 | Closed |
|
30
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$21.6K | -14,871 | Closed |
|
31
Verition Fund Management
Greenwich,
Connecticut
| – | -$21.4K | -14,760 | Closed |
|
|
CF
32
Cantor Fitzgerald
New York
| – | -$17.9K | -12,320 | Closed |
|
33
JP Morgan Chase
New York
| – | -$345 | -238 | Closed |
|
34
Wells Fargo
San Francisco,
California
| – | -$173 | -119 | Closed |
|
35
Nisa Investment Advisors
St. Louis,
Missouri
| – | -$146 | -101 | Closed |
|
36
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| – | -$117 | -63 | -93% |
|
|
EWA
37
EverSource Wealth Advisors
Birmingham,
Alabama
| – | -$4 | -3 | Closed |
|
CAMP Hedge Fund Activity: Q3 2025 in Review
29 of the 7,625 institutional investors tracked by Wall St. Rank reported a position in CAMP4 Therapeutics (CAMP) for Q3 2025, worth a combined $84.6M — up 397% from $17M a quarter earlier.
Fund positioning in CAMP was balanced in Q3 2025: 8 funds opened new positions, 8 closed out, 4 added to existing stakes and 10 trimmed.
The largest buyer was Janus Henderson Group, opening a new position worth an estimated $8.6M. The largest seller was BlackRock, cutting an estimated $135K.
- 29 institutional investors held CAMP4 Therapeutics (CAMP) as of Q3 2025, unchanged from Q2 2025.
- Funds reported $84.6M of CAMP4 Therapeutics stock for Q3 2025, up 397% quarter-over-quarter.
- 8 funds opened new CAMP4 Therapeutics positions in Q3 2025 and 8 closed out, a net change of 0 holders.
- The largest CAMP4 Therapeutics buyer in Q3 2025 was Janus Henderson Group, an estimated $8.6M added.
- The largest CAMP4 Therapeutics seller in Q3 2025 was BlackRock, an estimated $135K sold.
Based on aggregated 13F filings for Q3 2025.